Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythms

Circadian Regulation of the Hepatic Endobiotic and Xenobitoic Detoxification Pathways: The Time Matters

(2012) Ursula Prosenc Zmrzljak et al.   CHEMICAL RESEARCH IN TOXICOLOGY

First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study

(2012) George D. Demetri et al.   EUROPEAN JOURNAL OF CANCER

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial

(2011) Michael Fiegl et al.   BMC CANCER

Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARγ-dependent and PPARγ-independent pathways

(2011) Besstina E. Lyles et al.   CELL CYCLE

Results of a Phase II Trial of Gemcitabine Plus Doxorubicin in Patients with Recurrent Head and Neck Cancers: Serum C18-Ceramide as a Novel Biomarker for Monitoring Response

(2011) Sahar A. Saddoughi et al.   CLINICAL CANCER RESEARCH

Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart

(2011) Siripong Palee et al.   EXPERIMENTAL PHYSIOLOGY

Molecular Basis of Chronopharmaceutics

(2011) Shigehiro Ohdo et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Chronotherapy and the molecular clock: Clinical implications in oncology☆

(2010) Pasquale F. Innominato et al.   ADVANCED DRUG DELIVERY REVIEWS

Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring

(2010) Thiago da Silva Torres et al.   PATHOLOGY RESEARCH AND PRACTICE

Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines

(2010) Lu-Lu Fan   WORLD JOURNAL OF GASTROENTEROLOGY

Melatonin: Signaling mechanisms of a pleiotropic agent

(2009) Rüdiger Hardeland   BIOFACTORS

PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation

(2009) Yusheng Ren et al.   VASCULAR PHARMACOLOGY

Disruption of ERα signalling pathway by PPARγ agonists: evidences of PPARγ-independent events in two hormone-dependent breast cancer cell lines

(2008) Julie Lecomte et al.   BREAST CANCER RESEARCH AND TREATMENT